Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,030.00p
   
  • Change Today:
      32.00p
  • 52 Week High: 2,155.00
  • 52 Week Low: 1,424.00
  • Currency: UK Pounds
  • Shares Issued: 66.04m
  • Volume: 214,697
  • Market Cap: £1,340.55m
  • RiskGrade: 128
  • Beta: 0.05

Genus taps Andy Russell for CFO

By Iain Gilbert

Date: Thursday 13 Mar 2025

LONDON (ShareCast) - (Sharecast News) - Animal genetics business Genus revealed on Thursday that it had appointed Andy Russell to the role of chief financial officer.
Russell will join Genus on 1 August, taking over from Alison Henriksen, who will retire from Genus on 31 July after more than five years in the job.

Russell joins Genus from global medical device manufacturer Smith & Nephew, where he spent nearly 12 years as CFO.

Chief executive Jorgen Kokke said: "I am delighted that we have been able to secure an executive of Andy's caliber. His blend of deep finance expertise and strong commercial acumen will help us take Genus through the next stage of its development as we continue to pursue our strategic priorities".

As of 0930 GMT, Genus shares were up 0.63% at 1,926.0p.









Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,030.00p
Change Today 32.00p
% Change 1.60 %
52 Week High 2,155.00
52 Week Low 1,424.00
Volume 214,697
Shares Issued 66.04m
Market Cap £1,340.55m
Beta 0.05
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
88.96% below the market average88.96% below the market average88.96% below the market average88.96% below the market average88.96% below the market average
87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average
Price Trend
45.45% above the market average45.45% above the market average45.45% above the market average45.45% above the market average45.45% above the market average
74.47% above the sector average74.47% above the sector average74.47% above the sector average74.47% above the sector average74.47% above the sector average
Income
92.91% below the market average92.91% below the market average92.91% below the market average92.91% below the market average92.91% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
92.35% below the market average92.35% below the market average92.35% below the market average92.35% below the market average92.35% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 1
Sell 0
Strong Sell 0
Total 10
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 06-Mar-25 07-Nov-24
Paid 04-Apr-25 06-Dec-24
Amount 10.30p 21.70p

Trades for 23-May-2025

Time Volume / Share Price
16:35 150 @ 2,030.00p
16:20 40 @ 2,010.00p
16:20 46 @ 2,007.50p
16:02 4 @ 2,005.00p
16:02 30 @ 2,010.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page